Genetic variability and phylogeny of the High-Risk HPV-31, -33, -35, -52, and -58 in Central Brazil

Journal of Medical Virology

Volumn 81, Issue 4, 2009, Pages 685-692

  Raiol, Taina ^a   Wyant, Patrícia Soares ^a,b   De Amorim, Regina Maria Santos ^a   Cerqueira, Daniela Marreco ^a,c   Von Milanezi, Natália Gal ^a   De Brígido, Marcelo Macedo ^a   Sichero, Laura ^d   Martins, Cláudia Renata Fernandes ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b UNIVERSITY OF STUTTGART   (Germany)

^c Health Ministry   (Brazil)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

Central brazil; Genetic variability; HPV; Molecular variants; Viral phylogeny

Indexed keywords

ARTICLE; BRAZIL; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; INFECTION RISK; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; VIRUS DETECTION; VIRUS ISOLATION; CLASSIFICATION; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PAPILLOMA VIRUS; RISK; VIROLOGY; VIRUS INFECTION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

ONCOPROTEIN; VIRUS DNA;

BRAZIL; DNA, VIRAL; FEMALE; GENETIC VARIATION; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; RISK; SEQUENCE ANALYSIS, DNA;

EID: 62849093679     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21432     Document Type: Article

References (42)

1. Aho J, Hankins C, Tremblay C, Lang F, Forest P, Pourreaux K, Rouah F, Coutlee F, The Canadian Women's HIV Study Group. 2003. Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus- seropositive and -seronegative women. J Infect Dis 188:1517-1527.
2. Aho J, Hankins C, Tremblay C, Forest P, Pourreaux K, Rouah F, Coutlee F, Canadian Women's HIV Study Group. 2004. Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women. J Infect Dis 190:46-52.
3. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller WE, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389-3402.
4. Calleja-Macias IE, Kalantari M, Huh J, Ortiz-Lopez R, Rojas- Martinez A, Gonzalez-Guerrero JF, Williamson AL, Hagmar B, Wiley DJ, Villarreal L, Bernard HU, Barrera- Saldana HA. 2004. Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology 319:315-323.
5. Calleja-Macias IE, Villa LL, Prado JC, Kalantari M, Allan B, Williamson A-L, Chung L-P, Collins RJ, Zuna RE, Dunn ST, Chu T-Y, Cubie HA, Cuschieri K, von Knebel-Doeberitz M, Martins CR, Sanchez GI, Bosch FX, Munoz N, Bernard H-U. 2005. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus Type 16. J Virol 79:13630-13640.
6. Camara GN, Cerqueira DM, Oliveira AP, Silva EO, Carvalho LG, Martins CR. 2003. Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. Mem Inst Oswaldo Cruz 98:879-883.
7. Cerqueira DM, Moraes DS, Camara GN, Amaral FA, Oyama CN, dos Santos MQ, Martins CR. 2007. High HPV genetic diversity in women infected with HIV-1 in Brazil. Arch Virol 152:75-83.
8. Chan PKS, Li WH, Ma WI, Cheung JLK, Cheng AF. 1999. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and pre-cancerous lesions. JMed Virol 59:232-238.
9. Clifford GM, Smith JS, Aguado T, Franceschi S. 2003. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 89:101 -105.
10. Day PM, Thompson CD, Buck CB, Pang YYS, Lowy DR, Schiller JT. 2007. Neutralization of Human Papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol 81:8784-8792.
11. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Haunsen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
12. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA. 2005. Virus taxonomy: The eighth report of the international committee on taxonomy of viruses. 8th edition. London: Academic Press, Inc., 1259 p.
13. Felsenstein J. 1981. Evolutionary trees from DNA sequences: A maximum likelihood approach. J Mol Evol 17:368-376.
14. Gagnon S, Hankins C, Tremblay C, Forest P, Pourreaux K, Coutlee F, Canadian Women's HIV Study Group. 2004. Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women. J Infect Dis 190:1575-1585.
15. Gagnon S, Hankins C, Tremblay C, Pourreaux K, Forest P, Rouah F. Coulée F, The Canadian Women's HIV Study Group. 2005. Polymorphism of human papillomavirus type 31 isolates infecting the genital tract ofHIV-seropositive and HIV-seronegative women at risk for HIV infection. J Med Virol 75:213-221.
16. Gagnon S, Hankins C, Money D, Pourreaux K, Franco E, Coutle e F, The Canadian Women's HIV Study Group. 2007. Polymorphism of the L1 capsid gene and persistence of human papillomavirus type 52 infection in women at high risk or infected by HIV. J Acquir Immune Defic Syndr 44:61-65.
17. Garbuglia AR, Carletti F, Minosse C, Piselli P, Zaniratti MS, Serraino D, Capobianchi MR. 2007. Genetic variability in E6 and E7 genes of human papillomavirus -16, -18, -31, and -33 from HIV-1-positive women in Italy. New Microbiol 30:377-382.
18. Giuliano AR, Papenfuss M, Abrahamsen M, Denmanc C, de Zapien JG, Henzen JLN, Ortega L, de Gala EMB, Stephan J, Feng J, Baldwin S, Garcia F, Hatch K. 2001. Human papillomavirus infection at the United States-Mexico border: Implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev 10:1129-1136.
19. Hiller T, Poppelreuther S, Stubenrauch F, Iftner T. 2006. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification. Cancer Epidemiol Biomarkers Prev 15:1262-1267.
20. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, Kahn T, Kiviat N, Lancaster W, Mavromara-Nazos P, Labropoulou V, Mitrani-Rosenbaum S, Norrild B, Pillai MR, Stoerker J, Syrjaenen K, Syrjaenen S, Tay SK, Villa LL, Wheeler CM, Williamson AL,
21. Bernard HU. 1993. The genetic drift ofhuman papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67:6413-6423. IARC. 2007. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 90. Smokeless Tobacco Products, Inc.: Lyon. 689 p.
22. Kämmer C, Warthorst U, Torrez-Martinez N, Wheeler CM, Pfister H. 2000. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol 81:1975-1981.
23. Kel AE, GoBling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E. 2003. MATCH: A tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 31:3576-3579.
24. Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Ferreira S, Tellier P, Simao J, Matlashewski G, Roger M, Franco EL, Coutlee F. 2006. Human papillomavirus type 33 polymorphisms and high- grade squamous intraepithelial lesions of the uterine cervix. J Infect Dis 194:886-894.
25. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. 1989. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209-214.
26. O'Connor M, Chan SY, Bernard HU. 1995. Transcription Factor Binding Sites in the Long Control Region ofGenital HPVs. Human Papillomaviruses 1995 Compendium available at: http://hpv-web.lanl.gov/stdgen/virus/hpv/compendium/ htdocs/HTML-FILES/HPVcompintro4.html.
27. Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara-Nazos P, Labropoulou V, Pfister H, Tay SK, ter Meulen J, Villa LL, Bernard HU. 1993. Evolution ofhuman papillomavirus type 18: An ancient phylogenetic root in Africa and intratype diversity reflect coevolu- tion with human ethnic groups. J Virol 67:6424-6431.
28. Page RDM. 1996. TREEVIEW: An application to display phylogenetic trees on personal computers. Comput Appl Biosci 12:357-358.
29. Prado JC, Calleja-Macias IE, Bernard HU, Kalantari M, Macay SA, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Ortiz-Lopez R, Barrera-Saldana HA, Cubie HA, Cuschieri K, Von Knebel-Doeberitz M, Sanchez GI, Bosch FX, Villa LL. 2005. Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18. Virology 340:95-104.
30. Sasagawa T, Basha W, Yanazaki H, Inoue M. 2001. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 10:45-52.
31. Sichero L, Franco EL, Villa LL. 2005. Different P105 promoter activities among natural variants of human papillomavirus type 18. J Infect Dis 191:739-742.
32. Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL. 2007. High-grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 120:1763-1768.
33. Stewart AC, Eriksson AM, Manos MM, Munoz N, Bosch FX, Peto J, Wheeler CM. 1996. Intratype variation in 12 human papilloma- virus types: A worldwide perspective. J Virol 70:3127-3136.
34. Stoppler MC, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J. 1996. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J. Virol 70:6987-6993.
35. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680.
36. Touze A, de Sanjose S, Coursaget P, Almirall MR, Palacio V, Meijer CJL, Kornegay J, Bosch FX. 2001. Prevalence of anti-human papillomavirus type 16, 18 31 and 58 virus-like particles in women in the general population and in prostitutes. J Clin Microbiol 39:4344-4348.
37. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz NJ. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Pathology 189:12-19.
38. WHO. 2007. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summary report on HPV and cervical cancer statistics in Brazil. 2007.Available at www.who.int/.hpvcentre.
39. LF, Koutsky LA, Galloway DA, Kyspers J, Hughes JP, Wheeler CM. 1997. Genomic variation of human papillomavirus type 16 and risk for high-grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89:796-802.
40. Xin CY, Matsumoto K, Yoshikawa H, Yasugi T, Onda T, Nakagawa S, Yamada M, Nozawa S, Sekiya S, Hirai Y, Shiromizu K, Fujii T, Taketani Y. 2001. Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Lett 170:19-24.
41. Yamada T, Wheeler CM, Halpern AL, Stewart AM, Hildesheim A. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69:7743-7753.
42. zur Hausen H. 2002. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2:342-350.